Imaging of the liver for hepatocellular cancer.
نویسنده
چکیده
BACKGROUND Imaging of the liver is a key component in the detection, diagnosis, management, and follow-up of patients with hepatocellular carcinoma. METHODS The author uses his own experience as well as a review of pertinent literature to describe the capabilities and the limitations of the principal currently available imaging techniques for the liver. RESULTS Ultrasound is widely available, but sensitivity and specificity for small nodules are limited. Computed tomography effectively demonstrates extrahepatic lesions and can differentiate between cysts or hemangiomas and hepatocellular carcinomas. Magnetic resonance imaging better characterizes hepatic lesions, but positron emission tomography is of limited value. CONCLUSIONS Cross-sectional imaging with ultrasound, CT, or MRI is critical for nodule characterization in the cirrhotic liver, surgical planning of HCC, and treatment response evaluation.
منابع مشابه
Issues pertaining to PET imaging of liver cancer
Positron emission tomography (PET) imaging using 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) has proven valuable in the diagnosis, staging and restaging for many cancers. However, its application for liver cancer has remained limited owing in part to the relatively high background uptake of the tracer in the liver plus the significant variability of the tumor specific uptake in liver cancer among pa...
متن کاملEvaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines
Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...
متن کاملEvaluation of Silibinin effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) cell lines
Human hepatocellular carcinoma is one of the most common recurrent malignancies, for as much as, there is no effective therapy. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anticancer effects against human hepatocellular carcinoma, human prostate adenocarcinoma cells, human breast carcinoma cells, human ectocervical carcinoma cells, and human colon canc...
متن کاملRisk factors for liver cancer worldwide.
: In this short commentary, we discuss the most important risk factors for liver cancer. One of the most striking risks is infection with hepatitis B and C viruses, leading to chronic hepatitis, which may later develop into hepatocellular carcinoma (HCC). The use of alcohol may lead to cirrhosis, which is scarring the liver, is associated with 30 a more increase in HCC and 10-20 times more incr...
متن کاملCytotoxic Effect of Capparis spinosa L. on the PLC/PRF/5 Human Hepatocellular Carcinoma Cell Line
ABSTRACT Background and Objectives: Capparis spinosa has been used in traditional medicine for various applications including treatment of liver disorders and cancer. We studied the effects of this plant on cell proliferation and morphological characteristics of PLC/PRF/5 liver cancer cell line. Method...
متن کاملFDG-avid portal vein tumor thrombosis from hepatocellular carcinoma in contrast-enhanced FDG PET/CT
Objective(s): In this study, we aimed to describe the characteristics of portal vein tumor thrombosis (PVTT), complicating hepatocellular carcinoma (HCC) in contrast-enhanced FDG PET/CT scan. Methods: In this retrospective study, 9 HCC patients with FDG-avid PVTT were diagnosed by contrast-enhanced fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT), which is a comb...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cancer control : journal of the Moffitt Cancer Center
دوره 17 2 شماره
صفحات -
تاریخ انتشار 2010